Market Trends– category –
-
Metal-Organic Framework (MOF)-Driven Sensors Achieve Ultra-High Sensitivity of 0.32 pg/mL for Rapid Mycotoxin Detection in Food
ACS Publications USA Overview This review details recent advancements in Metal-Organic Framework (MOF)-driven sensors (MD sensors) for rapid early warning of mycotoxins in food. MD sensors offer advantages such as low cost, ultra-high de... -
ALR Technologies to Acquire CGM Medical Shenzhen, Boosting CGM Manufacturing Capacity to 300,000 Units Monthly by January 2027
ALR Technologies (Press Release) USA Overview ALR Technologies announced plans to acquire CGM Medical Shenzhen to enhance its development of accurate and affordable continuous glucose monitor (CGM) devices for diabetes management. This a... -
Bioprocessing Technologies Expand Beyond Pharma to Reshape Food Production, Environmental Applications, and Sustainable Manufacturing
LabX Media Group USA Overview Core bioprocessing technologies such as fermentation bioreactors, membrane filtration, and PAT sensors are extending their reach beyond pharmaceuticals into food, industrial enzymes, biofuels, and environmen... -
DLG Report Details Nanosensor Innovation in Food Industry: FluIDect for Real-time Quality Monitoring, Oxford Nanopore for Pathogen ID
DLG-Expert report Germany Overview According to a DLG expert report, nanosensors significantly enhance accuracy, sensitivity, and speed in food testing by detecting, quantifying, and monitoring chemical, physical, or biological parameter... -
MDPI: Nanoparticle-Based Biosensors Redefine Biomedical Diagnostics and Environmental Monitoring, Enhancing Pathogenic Nucleic Acid Detection Sensitivity
MDPI Switzerland Overview According to an editorial in MDPI, nanoparticle-based biosensors are redefining the future of biomedical diagnostics and environmental monitoring. Diagnostic platforms leveraging nanoparticles have significantly... -
July 2026 Digital Health Trends: AI Wearable Patch Hits 99.6% Arrhythmia Detection, Clair Health Secures $11.6M for Women’s Health Wearable
Digital Health Trends (Openloop Health blog) USA Overview June 2026 marked significant advancements in digital health. An AI wearable patch achieved 99.6% accuracy in detecting life-threatening arrhythmias, while Midjourney unveiled an u... -
GoodRx Compares Leading CGMs: Dexcom G7 10-Day Sensor Emerges as Sole FDA-Approved Device for Children Ages 2+
GoodRx USA Overview According to a GoodRx comparison report, the Dexcom G7 10-day sensor is FDA-approved for adults and children aged 2 and older, while the Dexcom G7 15-day sensor and Eversense 365 are approved exclusively for adults ag... -
CRP Point-of-Care Testing (POCT) Significantly Reduces Pediatric Antibiotic Prescriptions by 20-30%
Aidian フィンランド Overview New findings from two large-scale randomized controlled trials (COORDINATE and ARON) demonstrate that C-reactive protein (CRP) Point-of-Care Testing (POCT) can safely and effectively guide antibiotic use in c... -
China’s POCT Industry Enters ‘Golden Globalization Era’ Driven by EU IVDR Reforms and Global Outbreaks
Hangzhou AllTest Biotech CO.,LTD China Overview China's Point-of-Care Testing (POCT) industry is entering a 'golden era' of globalization, fueled by stricter EU IVDR regulations and frequent global infectious disease outbreaks. The EU IV... -
FDA Clears Dexcom Stelo as First OTC Continuous Glucose Monitor for Non-Insulin-Using Children (Ages 2+)
HCPLive USA Overview The FDA has approved Dexcom's Stelo Glucose Biosensor System for over-the-counter (OTC) use in children aged 2 years and older who do not use insulin. This marks Stelo as the first OTC continuous glucose monitoring (...
